Found: 82
Select item for more details and to access through your institution.
Pharmacokinetic study of capivasertib and the CYP3A4 substrate midazolam in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 94, n. 2, p. 223, doi. 10.1007/s00280-024-04667-3
- By:
- Publication type:
- Article
LY3022855, an anti–colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1057, doi. 10.1007/s10637-021-01084-8
- By:
- Publication type:
- Article
Phase I clinical trial of temozolomide and methoxyamine (TRC-102), an inhibitor of base excision repair, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 142, doi. 10.1007/s10637-020-00962-x
- By:
- Publication type:
- Article
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 738, doi. 10.1007/s10637-019-00768-6
- By:
- Publication type:
- Article
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 87, doi. 10.1007/s10637-018-0610-0
- By:
- Publication type:
- Article
Phase I study of the combination of quinacrine and erlotinib in patients with locally advanced or metastatic non small cell lung cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 435, doi. 10.1007/s10637-017-0515-3
- By:
- Publication type:
- Article
Evaluating the role of phase I expansion cohorts in oncologic drug development.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 1, p. 108, doi. 10.1007/s10637-016-0394-z
- By:
- Publication type:
- Article
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 729, doi. 10.1007/s10637-014-0078-5
- By:
- Publication type:
- Article
Phase II trial of Sorafenib in conjunction with chemotherapy and as maintenance therapy in extensive-stage small cell lung cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 362, doi. 10.1007/s10637-013-0061-6
- By:
- Publication type:
- Article
A Phase I Study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1244, doi. 10.1007/s10637-013-9945-8
- By:
- Publication type:
- Article
Temporal evolution of patient characteristics enrolled on phase I trials.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 312, doi. 10.1007/s10637-009-9362-1
- By:
- Publication type:
- Article
A phase I study of rebeccamycin analog in combination with oxaliplatin in patients with refractory solid tumors.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 1, p. 126, doi. 10.1007/s10637-009-9322-9
- By:
- Publication type:
- Article
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2009, v. 27, n. 5, p. 453, doi. 10.1007/s10637-008-9200-x
- By:
- Publication type:
- Article
Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 355, doi. 10.1007/s10637-008-9137-0
- By:
- Publication type:
- Article
Randomized phase II trial of different schedules of administration of rebeccamycin analogue as second line therapy in non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 6, p. 563, doi. 10.1007/s10637-005-0754-6
- By:
- Publication type:
- Article
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 8, p. 484, doi. 10.1002/ajh.21449
- By:
- Publication type:
- Article
A Phase 1 Dose-Escalation Study of PF-06671008, a Bispecific T-Cell-Engaging Therapy Targeting P-Cadherin in Patients With Advanced Solid Tumors.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.845417
- By:
- Publication type:
- Article
Multiple configurations of EGFR exon 20 resistance mutations after first- and third-generation EGFR TKI treatment affect treatment options in NSCLC.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0208097
- By:
- Publication type:
- Article
E-Cigarette Use and Lung Cancer Screening Uptake.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2419648, doi. 10.1001/jamanetworkopen.2024.19648
- By:
- Publication type:
- Article
Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 14, p. 7658, doi. 10.3390/ijms22147658
- By:
- Publication type:
- Article
Therapeutic challenges of AIDS-related non-Hodgkin's lymphoma in the United States and East Africa.
- Published in:
- 2002
- By:
- Publication type:
- journal article
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
- Published in:
- British Journal of Cancer, 2022, v. 126, n. 3, p. 514, doi. 10.1038/s41416-021-01536-1
- By:
- Publication type:
- Article
NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CBL0137 increases the targeting efficacy of Rovalpituzumab tesirine against tumour-initiating cells in small cell lung cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A first-in-human phase 1 and pharmacological study of TAS-119, a novel selective Aurora A kinase inhibitor in patients with advanced solid tumours.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase II and pharmacokinetic/pharmacodynamic trial of sequential topoisomerase I and II inhibition with topotecan and etoposide in advanced non-small-cell lung cancer.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00202-2
- By:
- Publication type:
- Article
Evaluation of O6-Benzylguanine-Potentiated Topical Carmustine for Mycosis Fungoides: A Phase 1-2 Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Effect of Pevonedistat, an Investigational NEDD8‐Activating Enzyme Inhibitor, on the QTc Interval in Patients With Advanced Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 3, p. 257, doi. 10.1002/cpdd.1194
- By:
- Publication type:
- Article
EFFECTS OF SOFTENED AND UNSOFTENED FABRICS ON INFANT SKIN.
- Published in:
- International Journal of Dermatology, 1994, v. 33, n. 2, p. 138, doi. 10.1111/j.1365-4362.1994.tb01547.x
- By:
- Publication type:
- Article
Outcomes of Antineoplastic Immunotherapy at a Large Healthcare Organization: Impact of Provider, Race and Socioeconomic Status.
- Published in:
- Cancer Management & Research, 2023, v. 15, p. 913, doi. 10.2147/CMAR.S403569
- By:
- Publication type:
- Article
Genomic analyses of high‐grade neuroendocrine gynecological malignancies reveal a unique mutational landscape and therapeutic vulnerabilities.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 12, p. 3545, doi. 10.1002/1878-0261.13057
- By:
- Publication type:
- Article
Identification of RUNX1T1 as a potential epigenetic modifier in small‐cell lung cancer.
- Published in:
- Molecular Oncology, 2021, v. 15, n. 1, p. 195, doi. 10.1002/1878-0261.12829
- By:
- Publication type:
- Article
Post‐transcriptional regulation of PIAS3 expression by miR‐18a in malignant mesothelioma.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 12, p. 2124, doi. 10.1002/1878-0261.12386
- By:
- Publication type:
- Article
Protein inhibitor of activated STAT3 expression in lung cancer
- Published in:
- Molecular Oncology, 2011, v. 5, n. 3, p. 256, doi. 10.1016/j.molonc.2011.03.004
- By:
- Publication type:
- Article
Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 1, p. 89, doi. 10.1111/j.1365-2141.2009.07836.x
- By:
- Publication type:
- Article
A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 10, p. 1163, doi. 10.1634/theoncologist.2016-0220
- By:
- Publication type:
- Article
Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 11, p. 1298, doi. 10.1634/theoncologist.2015-0136
- By:
- Publication type:
- Article
Phase II Study of Dasatinib (BMS-354825) in Patients With Metastatic Adenocarcinoma of the Pancreas.
- Published in:
- Oncologist, 2013, v. 18, n. 10, p. 1091, doi. 10.1634/theoncologist.2013-0255
- By:
- Publication type:
- Article
Phase I Study of Pazopanib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1253, doi. 10.1634/theoncologist.2010-0095
- By:
- Publication type:
- Article
Next Generation Sequencing of Advanced Non-Small Cell Lung Cancer: Utilization Based on Race and Impact on Survival.
- Published in:
- 2021
- By:
- Publication type:
- journal article
KMT2D Mutation Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1459, doi. 10.1002/cam4.2023
- By:
- Publication type:
- Article
PIAS3 expression in squamous cell lung cancer is low and predicts overall survival.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 3, p. 325, doi. 10.1002/cam4.372
- By:
- Publication type:
- Article
Pharmacogenomic Approach to Identify Drug Sensitivity in Small-Cell Lung Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 9, p. 1, doi. 10.1371/journal.pone.0106784
- By:
- Publication type:
- Article
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
- By:
- Publication type:
- Article
RESILIENT part 1: a phase 2 dose‐exploration and dose‐expansion study of second‐line liposomal irinotecan in adults with small cell lung cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 9, p. 1801, doi. 10.1002/cncr.34123
- By:
- Publication type:
- Article
JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 1, p. 65, doi. 10.1002/cncr.33885
- By:
- Publication type:
- Article
Slicing and dicing small cell lung cancer to improve trial outcomes.
- Published in:
- 2020
- By:
- Publication type:
- editorial
Stereotactic body radiotherapy (SBRT) for T2N0 (>3 cm) non-small cell lung cancer: Outcomes and failure patterns.
- Published in:
- Journal of Radiosurgery & SBRT, 2021, v. 7, n. 4, p. 271
- By:
- Publication type:
- Article